ORIGINAL RESEARCH article

Front. Nutr.

Sec. Clinical Nutrition

Volume 12 - 2025 | doi: 10.3389/fnut.2025.1594890

Acceptance and feasibility of novel staple foods among individuals with type 2 diabetes in Singapore: A mixed methods study

Provisionally accepted
Hafizah  YusriHafizah Yusri1Sean  Jun Leong OuSean Jun Leong Ou1Dimeng  YangDimeng Yang1Marcus  TingMarcus Ting1Salome  A RebelloSalome A Rebello2Chin Meng  KhooChin Meng Khoo3E Shyong  TaiE Shyong Tai2,3Mei Hui  LiuMei Hui Liu1*
  • 1Department of Food Science and Technology, Faculty of Science, National University of Singapore, Singapore, Singapore
  • 2Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore
  • 3Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore

The final, formatted version of the article will be published soon.

Introduction: Novel staple foods (NVSFs) are defined as modified staple foods that provide healthier alternatives to type 2 diabetes (T2D) patients aiming to improve postprandial glycemic responses. We explored the expectations and perceptions of participants with T2D towards NVSFs alongside their feasibility using a mixed methods approach.Methods: Three distinct NVSFs were investigated: (i) bread fortified with anthocyanins for carbohydrase inhibition; (ii) white rice fortified with fibre; and (iii) microfluidic gel noodles reduced in available carbohydrates. Sixteen individuals with T2D participated in a 5-week crossover study where NVSFs or control staple foods were consumed in mixed meals for breakfast, lunch, and dinner. Participants wore continuous glucose monitoring devices during interventions to measure postprandial glycemic responses and interviews were conducted before and after interventions.Results: Qualitative analysis from interviews identified participants' prior dietary choices, prior NVSF perceptions, expectations, and impressions, trade-offs between sensory and healthfulness, price, modification methods, and other socio-economic regular consumption considerations as key factors contributing to the acceptance of NVSFs. Among the NVSFs, the anthocyanin-fortified bread and fibre-fortified rice were preferred for their palatability, but not the microfluidic noodles. However, quantitative analysis from continuous glucose monitoring revealed only the microfluidic noodle meal demonstrating a significant reduction in 2-hour iAUC value relative to its control from 160.2 ± 17.6 to 114.3 ± 12.2 mmol/L.min (mean ± SEM) p=0.046.Discussion: This highlights the challenge of attaining a balance between health and favorable sensory properties for these NVSFs, which may be attributed to their modification methods. We conclude that an alternative staple food with palatable taste and texture properties modified through the reduction of available carbohydrates may be an effective approach to enhance the acceptance and feasibility of modified staple foods for T2D management.

Keywords: Staple Foods, type 2 diabetes, Continuous glucose monitoring, Consumer perceptions, interviews, mixed method analysis. (Min

Received: 17 Mar 2025; Accepted: 23 May 2025.

Copyright: © 2025 Yusri, Ou, Yang, Ting, Rebello, Khoo, Tai and Liu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Mei Hui Liu, Department of Food Science and Technology, Faculty of Science, National University of Singapore, Singapore, 117543, Singapore

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.